Government

Image description

FDA approves Genentech’s Rituxan Hycela

Rituxan Hycela contains hyaluronidase human, an enzyme that helps with the subcutaneous delivery of Rituxan's active ingredient, rituximab, allowing for faster administration compared with intravenous Rituxan.

Image description

Compounded meds legislation introduced in House

The Preserving Patient Access to Compounded Medications Act of 2017 would clarify the Drug Quality and Security Act in a way that would align the statute with congressional intent to balance the issues of public safety and patient access. 

Image description

Oregon passes DXM age restriction law

The move makes Oregon the 14th state to pass a law banning dextromethorphan sales to patients younger than 18 years old, joining states across the country in recognizing that limiting teen access to DXM is a proven way to prevent abuse, the Consumer Healthcare Products Association said.

Image description

Looking beyond influenza immunizations

In PrescribeWellness’ 2017 Vaccination and Preventive Care Study, 55% of survey respondents said they prefer their pharmacy to their physician’s office as the place to get vaccinated.

Image description

CRN’s Supplement OWL goes live

The Council for Responsible Nutrition’s Supplement OWL is an online product registry that serves as resource for regulators, retailers and the industry, and can be accessed by anyone.